Do analysts prefer PLUT or AIKI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Plutus Financial Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, PLUT or AIKI?

Plutus Financial Group has higher revenue and earnings than AIkido Pharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Plutus Financial Group $10.44M 4.00 -$5.06M N/A N/A AIkido Pharma N/A N/A -$7.17M -$3.88 N/A

Is PLUT or AIKI more profitable?

Plutus Financial Group's return on equity of 0.00% beat AIkido Pharma's return on equity. Company Net Margins Return on Equity Return on Assets Plutus Financial Group N/A N/A N/A AIkido Pharma N/A -18.21% -16.94%

Do analysts recommend FTFT or AIKI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Future FinTech Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend AIKI or MDBH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 MDB Capital 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is AIKI or MDBH more profitable?

AIkido Pharma's return on equity of -18.21% beat MDB Capital's return on equity. Company Net Margins Return on Equity Return on Assets AIkido Pharma N/A -18.21% -16.94% MDB Capital N/A -39.77% -38.48%

Do analysts prefer GRAN or AIKI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Grande Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, GRAN or AIKI?

Grande Group has higher revenue and earnings than AIkido Pharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Grande Group $1.81M 15.00 -$3.47M N/A N/A AIkido Pharma N/A N/A -$7.17M -$3.88 N/A

Is GRAN or AIKI more profitable?

Grande Group's return on equity of 0.00% beat AIkido Pharma's return on equity. Company Net Margins Return on Equity Return on Assets Grande Group N/A N/A N/A AIkido Pharma N/A -18.21% -16.94%

Do analysts rate AIKI or BCG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Binah Capital Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

AIkido Pharma (AIKI) Competitors

$2.10 -0.14 (-6.25%)

As of 10/5/2026

Compare

AIKI vs. PLUT, FTFT, MDBH, GRAN, and BCG

Should you buy AIkido Pharma stock or one of its competitors? AIkido Pharma's main competitors and comparable companies include Plutus Financial Group (PLUT), Future FinTech Group (FTFT), MDB Capital (MDBH), Grande Group (GRAN), and Binah Capital Group (BCG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "investment banking & brokerage" industry.

How does AIkido Pharma compare to Plutus Financial Group?

Plutus Financial Group (NASDAQ:PLUT) and AIkido Pharma (NASDAQ:AIKI) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Plutus Financial Group has higher revenue and earnings than AIkido Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Plutus Financial Group	$10.44M	4.00	-$5.06M	N/A	N/A
AIkido Pharma	N/A	N/A	-$7.17M	-$3.88	N/A

In the previous week, Plutus Financial Group had 2 more articles in the media than AIkido Pharma. MarketBeat recorded 2 mentions for Plutus Financial Group and 0 mentions for AIkido Pharma. AIkido Pharma's average media sentiment score of 0.00 beat Plutus Financial Group's score of -0.02 indicating that AIkido Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Plutus Financial Group	Neutral
AIkido Pharma	Neutral

Plutus Financial Group has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market. Comparatively, AIkido Pharma has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

Plutus Financial Group's return on equity of 0.00% beat AIkido Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Plutus Financial Group	N/A	N/A	N/A
AIkido Pharma	N/A	-18.21%	-16.94%

10.9% of AIkido Pharma shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Plutus Financial Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AIkido Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Plutus Financial Group beats AIkido Pharma on 7 of the 10 factors compared between the two stocks.

How does AIkido Pharma compare to Future FinTech Group?

Future FinTech Group (NASDAQ:FTFT) and AIkido Pharma (NASDAQ:AIKI) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

In the previous week, Future FinTech Group had 1 more articles in the media than AIkido Pharma. MarketBeat recorded 1 mentions for Future FinTech Group and 0 mentions for AIkido Pharma. Future FinTech Group's average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score.

Company	Overall Sentiment
Future FinTech Group	Neutral
AIkido Pharma	Neutral

0.2% of Future FinTech Group shares are held by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are held by institutional investors. 1.5% of Future FinTech Group shares are held by insiders. Comparatively, 8.6% of AIkido Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AIkido Pharma has a net margin of 0.00% compared to Future FinTech Group's net margin of -157.53%. Future FinTech Group's return on equity of -12.22% beat AIkido Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Future FinTech Group	-157.53%	-12.22%	-10.08%
AIkido Pharma	N/A	-18.21%	-16.94%

Future FinTech Group has higher revenue and earnings than AIkido Pharma. AIkido Pharma is trading at a lower price-to-earnings ratio than Future FinTech Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Future FinTech Group	$3.83M	8.50	-$4.62M	-$30.16	N/A
AIkido Pharma	N/A	N/A	-$7.17M	-$3.88	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Future FinTech Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AIkido Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Future FinTech Group has a beta of 1.7, suggesting that its stock price is 70% more volatile than the broader market. Comparatively, AIkido Pharma has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market.

Summary

Future FinTech Group beats AIkido Pharma on 8 of the 12 factors compared between the two stocks.

How does AIkido Pharma compare to MDB Capital?

AIkido Pharma (NASDAQ:AIKI) and MDB Capital (NASDAQ:MDBH) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AIkido Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
MDB Capital	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

AIkido Pharma has higher earnings, but lower revenue than MDB Capital. MDB Capital is trading at a lower price-to-earnings ratio than AIkido Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AIkido Pharma	N/A	N/A	-$7.17M	-$3.88	N/A
MDB Capital	$4.91M	4.66	-$21.25M	-$2.18	N/A

AIkido Pharma's return on equity of -18.21% beat MDB Capital's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AIkido Pharma	N/A	-18.21%	-16.94%
MDB Capital	N/A	-39.77%	-38.48%

AIkido Pharma has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market. Comparatively, MDB Capital has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

10.9% of AIkido Pharma shares are held by institutional investors. Comparatively, 0.4% of MDB Capital shares are held by institutional investors. 8.6% of AIkido Pharma shares are held by insiders. Comparatively, 55.8% of MDB Capital shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, AIkido Pharma's average media sentiment score of 0.00 equaled MDB Capital'saverage media sentiment score.

Company	Overall Sentiment
AIkido Pharma	Neutral
MDB Capital	Neutral

Summary

AIkido Pharma and MDB Capital tied by winning 5 of the 10 factors compared between the two stocks.

How does AIkido Pharma compare to Grande Group?

Grande Group (NASDAQ:GRAN) and AIkido Pharma (NASDAQ:AIKI) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grande Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AIkido Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Grande Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. Comparatively, AIkido Pharma has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

Grande Group has higher revenue and earnings than AIkido Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grande Group	$1.81M	15.00	-$3.47M	N/A	N/A
AIkido Pharma	N/A	N/A	-$7.17M	-$3.88	N/A

Grande Group's return on equity of 0.00% beat AIkido Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Grande Group	N/A	N/A	N/A
AIkido Pharma	N/A	-18.21%	-16.94%

In the previous week, Grande Group's average media sentiment score of 1.08 beat AIkido Pharma's score of 0.00 indicating that Grande Group is being referred to more favorably in the media.

Company	Overall Sentiment
Grande Group	Positive
AIkido Pharma	Neutral

10.9% of AIkido Pharma shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Grande Group beats AIkido Pharma on 6 of the 9 factors compared between the two stocks.

How does AIkido Pharma compare to Binah Capital Group?

AIkido Pharma (NASDAQ:AIKI) and Binah Capital Group (NASDAQ:BCG) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Binah Capital Group has a net margin of 2.17% compared to AIkido Pharma's net margin of 0.00%. Binah Capital Group's return on equity of 195.38% beat AIkido Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AIkido Pharma	N/A	-18.21%	-16.94%
Binah Capital Group	2.17%	195.38%	5.95%

10.9% of AIkido Pharma shares are owned by institutional investors. Comparatively, 5.0% of Binah Capital Group shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by company insiders. Comparatively, 7.8% of Binah Capital Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AIkido Pharma has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market. Comparatively, Binah Capital Group has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market.

Binah Capital Group has higher revenue and earnings than AIkido Pharma. AIkido Pharma is trading at a lower price-to-earnings ratio than Binah Capital Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AIkido Pharma	N/A	N/A	-$7.17M	-$3.88	N/A
Binah Capital Group	$187.14M	0.10	$2.31M	$0.18	5.83

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AIkido Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Binah Capital Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Binah Capital Group had 2 more articles in the media than AIkido Pharma. MarketBeat recorded 2 mentions for Binah Capital Group and 0 mentions for AIkido Pharma. AIkido Pharma's average media sentiment score of 0.00 equaled Binah Capital Group'saverage media sentiment score.

Company	Overall Sentiment
AIkido Pharma	Neutral
Binah Capital Group	Neutral

Summary

Binah Capital Group beats AIkido Pharma on 9 of the 12 factors compared between the two stocks.

Get AIkido Pharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIKI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIKI vs. The Competition

Export

Metric	AIkido Pharma	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	$11.52M	$5.16B	$13.43B	$13.39B
Dividend Yield	N/A	7.58%	6.04%	18.16%
P/E Ratio	-0.54	29.97	24.62	26.34
Price / Sales	N/A	1,289.57	518.97	95.03
Price / Cash	N/A	47.69	43.98	53.24
Price / Book	0.11	3.49	2.71	6.33
Net Income	-$7.17M	$415.67M	$1.31B	$381.26M
7 Day Performance	-15.32%	-0.17%	-0.22%	-0.61%
1 Month Performance	N/A	-2.77%	-3.18%	-4.84%
1 Year Performance	-71.19%	11.09%	11.24%	1.12%

AIkido Pharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIKI AIkido Pharma	N/A	$2.10 -6.3%	N/A	-69.3%	$11.52M	N/A	N/A	4
PLUT Plutus Financial Group	0.4408 of 5 stars	$2.52 +7.9%	N/A	-23.8%	$38.61M	$1.34M	N/A	9	Gap Down
FTFT Future FinTech Group	0.1556 of 5 stars	$3.36 -1.2%	N/A	-97.5%	$31.52M	$3.83M	N/A	33
MDBH MDB Capital	0.7278 of 5 stars	$2.41 -7.6%	N/A	-35.3%	$24.83M	$4.91M	N/A	14	Positive News Gap Down
GRAN Grande Group	N/A	$0.98 -10.3%	N/A	-66.0%	$24.39M	$1.81M	N/A	24

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIKI) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AIkido Pharma (AIKI) Competitors

AIKI vs. PLUT, FTFT, MDBH, GRAN, and BCG

How does AIkido Pharma compare to Plutus Financial Group?

Summary

How does AIkido Pharma compare to Future FinTech Group?

Summary

How does AIkido Pharma compare to MDB Capital?

Summary

How does AIkido Pharma compare to Grande Group?

Summary

How does AIkido Pharma compare to Binah Capital Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIKI vs. The Competition

AIkido Pharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AIkido Pharma (AIKI) Competitors

AIKI vs. PLUT, FTFT, MDBH, GRAN, and BCG

How does AIkido Pharma compare to Plutus Financial Group?

Which has stronger valuation and earnings, PLUT or AIKI?

Does the media favor PLUT or AIKI?

Which has more risk & volatility, PLUT or AIKI?

Is PLUT or AIKI more profitable?

Do insiders & institutionals hold more shares of PLUT or AIKI?

Do analysts prefer PLUT or AIKI?

Summary

How does AIkido Pharma compare to Future FinTech Group?

Does the media favor FTFT or AIKI?

Do insiders & institutionals hold more shares of FTFT or AIKI?

Is FTFT or AIKI more profitable?

Which has better valuation and earnings, FTFT or AIKI?

Do analysts recommend FTFT or AIKI?

Which has more volatility & risk, FTFT or AIKI?

Summary

How does AIkido Pharma compare to MDB Capital?

Do analysts recommend AIKI or MDBH?

Which has higher earnings and valuation, AIKI or MDBH?

Is AIKI or MDBH more profitable?

Which has more risk and volatility, AIKI or MDBH?

Do insiders & institutionals have more ownership in AIKI or MDBH?

Does the media favor AIKI or MDBH?

Summary

How does AIkido Pharma compare to Grande Group?

Do analysts prefer GRAN or AIKI?

Which has more volatility & risk, GRAN or AIKI?

Which has stronger earnings & valuation, GRAN or AIKI?

Is GRAN or AIKI more profitable?

Does the media refer more to GRAN or AIKI?

Do insiders & institutionals have more ownership in GRAN or AIKI?

Summary

How does AIkido Pharma compare to Binah Capital Group?

Is AIKI or BCG more profitable?

Do insiders and institutionals believe in AIKI or BCG?

Which has more risk and volatility, AIKI or BCG?

Which has preferable earnings and valuation, AIKI or BCG?

Do analysts rate AIKI or BCG?

Does the media favor AIKI or BCG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIKI vs. The Competition

AIkido Pharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools